Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
Correlation between changes in glucose infusion rate at euglycemic-hyperinsulinemic clamp and clinical variables in patients treated with liraglutide.
Changes in body mass index
Changes in hemoglobin A1c (%)
Changes in fasting blood glucose (mg/dL)
Changes in fasting blood insulin (µU/mL)
Changes in fasting blood CPR (ng/mL)
Changes in postprandial blood glucose (mg/dL)
Changes in postprandial blood insulin (µU/mL)
Changes in postprandial blood CPR (ng/mL)
CPR: C-peptide radioimmunoreactivity.
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.